Do you want to read an article? Please log in or register.
Prevalence and prognostic significance of interstitial lung abnormalities in lung cancer: A meta-analysis
Lung, Respiratory and Thoracic Cancer
Related content
Lung, Respiratory and Thoracic Cancer
Prevalence of osimertinib-induced cardiotoxicity in non-small cell lung cancer patients: a systematic review and meta-analysis
Lung Cancer
Gawli CS, Patil BR, Nagpure NR, Patil CR, Kumar A, Patel HM
doi: 10.1016/j.lungcan.2025.108629
Gastrointestinal Cancer
Prognostic significance of pre-treatment immune-inflammation biomarkers in anal cancer: A study combining real-world data and a meta-analysis
Int J Cancer
Wind KL, Steffensen JH, Jakobsen AV, Kronborg C, Spindler KG
doi: 10.1002/ijc.35404
Lung, Respiratory and Thoracic Cancer
A new proposal of simplified classification of non-small cell lung cancer oligometastases for easy applicability through systematic literature analysis and meta-analysis validation
Eur J Cancer
Kang H, Do W, Ahn YC, Chie EK, Rim CH, On behalf of, Korean Oligometastasis Working Group (K-OWG)
doi: 10.1016/j.ejca.2024.115043
Lung, Respiratory and Thoracic Cancer
Validation of the Lung Immune Prognostic Index in patients with untreated advanced non-small cell lung cancer: Post hoc analysis of the IMpower 130, 131 and 150 trials
Lung Cancer
Auclin E, Roulleaux Dugage M, Gorria T, Vauchier C, Thibault C, Laguna JC, Lupinacci L, Crous C, Naigeon M, Oudard S, Besse B, Mezquita L
doi: 10.1016/j.lungcan.2024.108039
Lung, Respiratory and Thoracic Cancer
Evaluating the safety of antibody-drug conjugates in lung cancer: A systematic review and meta-analysis
Lung Cancer
He Q, Jiang L, Xu Y, Wang M
doi: 10.1016/j.lungcan.2025.108425
Further Publications
Antibody-drug conjugate components in association with the incidence of ADC-related interstitial lung disease: A systematic review and meta-analysis
Lung Cancer
Shao T, Yang J, Chen J, Zhang Y, Shou L
doi: 10.1016/j.lungcan.2025.108559
RECOMMENDED
Lung, Respiratory and Thoracic Cancer
Long term outcomes after lobar versus sublobar resection for patients with Non-Small cell lung Cancer: Systematic review and individual patient data Meta-Analysis
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
Lung Cancer
Tasoudis P, Loufopoulos G, Manaki V, Doerr M, Agala CB, Long JM, Haithcock BE
doi: 10.1016/j.lungcan.2024.107929
Lung, Respiratory and Thoracic Cancer
Efficacy and safety of targeted therapy combined with anti-angiogenesis treatment in brain metastases of non-small cell lung cancer: a systematic review and meta-analysis
Lung Cancer
Pan Y, Gu Q
doi: 10.1016/j.lungcan.2025.108532
Lung, Respiratory and Thoracic Cancer
Comparative effectiveness and safety of tislelizumab versus other anti-PD-(L)1 agents in first- and subsequent lines in locally advanced or metastatic non-small cell lung cancer: Systematic literature review and network meta-analysis
Lung Cancer
Girard N, Han JY, Soo RA, Wang K, Tang W, Nikolaidis GF, Tasoulas A, Barouma I, Castro JC, Yang Z, Chaudhary T, Zhan L
doi: 10.1016/j.lungcan.2025.108450